Is it safe to take statin medications in terms of brain health? So many patients at the Kahn Center express their fear of having brain damage from statin medications so new information is crucial.
ABSTRACT HIGHLIGHTS:
“Dementia affects 55 million people globally, with the number projected to triple by 2050. Statins, widely prescribed for cardiovascular benefits, may also have neuroprotective effects, although studies on their impact on dementia risk have shown contradictory results. In this systematic review and meta-analysis, we searched PubMed, Embase, and Cochrane following Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines. We assessed the risk of dementia, Alzheimer’s disease (AD), and vascular dementia (VaD), with subgroup analyses by gender, statin type, and diabetes status.”
“Our findings underscore the neuroprotective potential of statins in dementia prevention. Despite the inherent limitations of observational studies, the large dataset and detailed subgroup analyses enhance the reliability of our results. Future randomized clinical trials are necessary to confirm these findings and enlighten clinical guidelines.”
“Largest meta-analysis to date on statins and dementia risk, including 55 studies and more than 7 million patients. Statin use is linked to lower risks of all-dementia, AD, and VaD. Numerous significant subgroup results highlight statins’ diverse neuroprotective effects. Findings support statins as a public health tool, especially in low-income countries. Future research should explore the impact of statins across diverse patient populations.”
THE STATIN MEDICATIONS STUDY
In this systematic review and meta-analysis, we searched PubMed, Embase, and Cochrane databases for studies on statin medications and brain health.
The authors assessed the risk of dementia, Alzheimer’s disease (AD), and vascular dementia (VaD), with subgroup analyses by gender, statin type, and diabetes status. Fifty-five observational studies including over 7 million patients were analyzed.
RESULTS
The use of statin medications significantly reduced the risk of dementia compared to nonusers by 14%.
The use of statin medications was also associated with reduced risks of AD by 18% and VaD by 11%.
Subgroup analyses revealed significant dementia risk reductions among patients with type 2 diabetes mellitus by 13%, those with exposure to statin medications for more than 3 years by 63%, and populations from Asia, where the greatest protective effect was observed by 16%.
Additionally, rosuvastatin demonstrated the most pronounced protective effect for all-cause dementia among specific statins by 28%.
DISCUSSION
The research findings underscore the neuroprotective potential of statins in dementia prevention.
Despite the inherent limitations of observational studies, the large dataset and detailed subgroup analyses enhance the reliability of our results.
Future randomized clinical trials are necessary to confirm these findings and enlighten clinical guidelines.
From the perspective of the Kahn Center, if it is advised to take statin medications, as low a dose as possible, combined with CoQ10, fearing brain health is misdirected.
About the author: Dr. Joel Kahn is one of the world’s top cardiologists and he is passionate about scientifically showing the body’s ability to heal itself through proper nutrition. He is on a mission to try to prevent heart disease and all future heart attacks by educating and inspiring people to follow an active and holistic lifestyle by applying cutting-edge science to their lives.
At his core, Dr. Joel Kahn believes that plant-based nutrition is the most powerful source of preventative medicine on the planet. Having practiced traditional cardiology since 1983, it was only after his own commitment to a plant-based vegan diet that Dr. Kahn truly began to delve into the realm of non-traditional diagnostic tools, prevention tactics, and nutrition-based recovery protocols.
As with anything you read on the internet, this article should not be construed as medical advice; please talk to your doctor or primary care provider before changing your wellness routine. WHN does not agree or disagree with any of the materials posted. This article is not intended to provide a medical diagnosis, recommendation, treatment, or endorsement. Additionally, it is not intended to malign any religion, ethnic group, club, organization, company, individual, or anyone or anything. These statements have not been evaluated by the Food and Drug Administration.
Content may be edited for style and length.
References/Sources/Materials provided by:
